You Searched For "favipiravir" and got 11 results
Sort By:
Biophore seeks approval for Aviptadil from India's drug controller for emergency use in COVID-19 treatment
The company plans to commence commercial production of the product immediately after the approv…
PTI
FDC launches two variants of COVID-19 drug Favipiravir in India at ₹55 per tablet
FDC has launched two variants of Favipiravir in India at ₹55 per tablet under the brand names PiFLU…
Indoco Remedies launches 400mg tablets of Favipiravir in India
Indoco Remedies, on September 26, launched its own version of generic Favipiravir under the brand n…
Hyderabad's Avra Labs to make Favipiravir for Cipla's Ciplenza
Hyderabad-based Avra Laboratories Pvt Ltd announced on Monday that it had received regulatory app…
There are five companies making Favipiravir now — and it is good for supply and prices
After Glenmark and Cipla, two more Indian pharma companies — Sun Pharmaceuticals and Zendara Pharma…
Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment
Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that …
COVID-19 treatment: Dr Reddy's partners with Fujifilm, GRA for favipiravir
Fujifilm will provide Dr Reddy's and GRA an array of data on Avigan's preclinical and clinical stud…
PTI
Interview: Glenmark Chairman has his hopes pinned on a flu drug Favipiravir to cure COVID-19
In an interview Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals, said the …
Glenmark gets DCGI nod for favipiravir for treatment of COVID-19 patients '
"This approval has been granted based on evaluation of data and in consultation with the Subject Ex…
PTI
Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients
"Several health and medical experts, both in and outside of Glenmark are eager to see the effect t…
PTI
Glenmark Pharma gets DCGI nod for clinical trials of Favipiravir tablets on COVID-19 patients
Having internally developed the active pharmaceutical ingredients (API) and the formulations for t…